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Differential effects of glutathione and cysteine on Fe21, Fe31, H2O2 and
myoglobulin-induced proximal tubular cell attack. Glutathione (GSH) is
widely advocated as a cytoprotectant for preventing oxidant forms of renal
damage. However, in the case of myoglobinuric tubular injury, both
beneficial and adverse effects have been noted. The purpose of this study
was to help elucidate this seeming paradox by assessing the impact on thiol
supplementation on normal tubules and on tubules subjected to individual
components of heme protein-induced oxidant attack (Fe21, Fe31, and
H2O2). Isolated mouse proximal tubular segments (PTS) were exposed to
either GSH or cysteine under normal conditions or in the presence of
exogenous Fe21, Fe31, or H2O2. Lethal cell injury (LDH release) and lipid
peroxidation (malondialdehyde) were then assessed. GSH and cysteine
exerted iron dependent, H2O2 independent, pro-oxidant effects on normal
PTS. Both were also pro-oxidant in the presence of an exogenous Fe31
challenge. In contrast, each attenuated Fe21 cytotoxicity. The importance
of iron’s redox status on the expression of tubular injury was further
underscored by the fact that Fe31 partially blocked Fe21’s cytotoxic
effects. GSH mitigated H2O2 toxicity (consistent with a fueling of GSH
peroxidase activity). Conversely, cysteine promoted H2O2’s injurious
effects. To assess the impact of thiol supplementation on a fully integrated
model of heme protein toxicity, proximal tubular (HK-2) cells were
cultured with myoglobin 3 24 hours 6 test reactants. Exogenous GSH
worsened, while GSH depletion (BSO) protected, against myoglobin
toxicity (indicating a predominance of GSH’s pro-oxidant effects). Con-
versely, cysteine (but not homocysteine) decreased myoglobin toxicity.
These GSH/cysteine effects were confirmed in LLC-PK1 cells subjected to
iron attack. We conclude that: (1) GSH and cysteine can exert pro- and
anti-oxidant effects, depending on the nature of the oxidant challenge and
iron’s redox status; (2) Fe31 can function as a cytoprotectant, partially
offsetting Fe21 toxicity; and (3) cysteine, although potentially pro-oxidant,
can mitigate heme protein-induced injury. Since the kidney rapidly
catabolizes GSH to cysteine, the latter may be at least partially responsible
for GSH’s reported cytoprotective actions against myoglobinuric acute
renal failure.
Iron-driven oxidant stress has been identified as a dominant
mechanism in the induction of heme protein-induced proximal
tubular cell injury and myohemoglobinuric acute renal failure
(ARF). The following pieces of experimental evidence support
this view: (1) administration of an iron chelator, deferoxamine
(DFO), attenuates the glycerol model of rhabdomyolysis-induced
ARF [1–3]; (2) when heme loaded proximal tubular segments are
exposed to DFO, decreased lipid peroxidation and cell death
results [4]; (3) DFO completely blocks the expression of myoglo-
bin cytotoxicity in cultured human proximal tubular (HK-2) cells
[5]; (4) inhibition of heme oxygenase, the enzyme that liberates
heme iron from its porphyrin ring, fully reproduces DFO’s
protective effect [5]; and (5) increased expression of ferritin (an
iron sequestering protein) mitigates myohemoglobinuric ARF [6,
7].
Although the above information irrefutably incriminates iron as
the critical initiator of heme protein-induced proximal tubular
injury, the reactive oxidants that secondarily mediate this toxicity
are less well defined [8]; however, H2O2 appears to be critically
involved. First, Guidet and Shah documented increased H2O2
generation in rat renal cortex following experimental myohemo-
globinuria, as assessed by the aminotriazole technique [9]. Sec-
ond, our laboratory has observed ;10-fold increments in H2O2
generation in isolated tubules extracted from myohemoglobinuric
mice (by phenol red/horseradish peroxidase assay; [5] and unpub-
lished data). Third, iron addition to isolated tubules directly
stimulates H2O2 generation [5]; and fourth, when cultured human
proximal tubular (HK-2) cells are exposed to myoglobin in the
presence of catalase, virtual complete cytoprotection results [5].
The latter underscores that H2O2 is a critical participant in, and
not simply a marker of, myohemoglobin-induced proximal tubular
cell death.
Although catalase can block in vitro myoglobinuric toxicity [5],
its large size prevents glomerular filtration, thereby precluding a
possible in vivo therapeutic effect. Conversely, glutathione (GSH),
the substrate for the H2O2 scavenging enzyme glutathione perox-
idase, gains ready tubular access [11, 12]. Once filtered, GSH is
transported into tubular cells by a process of: (i) luminal degra-
dation into its constituent amino acids (cysteine, glycine, gluta-
mate); (ii) tubular cell uptake of these amino acids, and then (iii)
intracellular GSH re-synthesis [11, 12]. In addition, a direct
basolateral membrane GSH transport system exists [13]. These
considerations suggest that GSH therapy could be a rational
alternative to catalase for preventing myohemoglobinuric ARF.
Nevertheless, inconsistent data regarding the efficacy of GSH in
this setting exist. For example, although Abul-Ezz, Walker and
Shah observed that GSH administration conferred modest pro-
tection against the glycerol model of myohemoglobinuric ARF
[14], we noted that GSH addition to heme loaded isolated tubules
exacerbated lipid peroxidation [4] and increased myoglobin-
induced HK-2 cell death [5]. That GSH supplementation has been
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reported to both protect against [15] and worsen [16, 17] another
model of ARF, renal artery occlusion, adds to this controversy.
Given that GSH is widely advocated as a potentially useful
renal antioxidant in many experimental settings, the present study
was undertaken to better define its influence on proximal tubular
cell integrity. The following specific questions have been ad-
dressed: (1) What is the impact of GSH treatment on normal
tubules and on tubules subjected to iron-mediated oxidant attack?
(2) Are GSH’s effects determined, at least in part, by iron’s
oxidation status? (3) Does GSH protect proximal tubules against
H2O2 cytotoxicity, and if so, might GSH degradation to cysteine
alter this result? (4) What are the mechanism(s) by which GSH
may, under selected circumstances, accentuate heme protein
cytotoxicity [4, 5]? and (5) Are GSH’s purported beneficial effects
against in vivo myohemoglobinuric ARF directly linked to H2O2
“scavenging,” or might alternative consequences of GSH admin-
istration be involved?
METHODS
Isolated proximal tubule segment preparation
Male CD-1 mice (30 to 40 g; Charles River Laboratory,
Wilmington, MA, USA), maintained under standard vivarium
conditions, were used to isolate proximal tubular segments (PTS)
by a previously described technique [18]. In brief, the mice were
anesthetized with pentobarbital (2 mg/kg; i.p.), the kidneys were
resected through a midline abdominal incision, they were cooled
on an iced plate, and the cortices were dissected, minced, and
digested for 30 minutes with a collagenase containing buffer.
Following digestion, the tissues were washed and centrifuged
through 32% Percoll, thereby isolating viable PTS. The pelleted
tubules were re-washed, suspended in an experimentation buffer
(in mmol/liters: NaCl, 100; KCl, 2.1; NaHCO3, 25; KH2PO4, 2.4;
MgSO4, 1.2; MgCl2, 1.2; CaCl2, 1.2; glucose, 5; alanine, 1; Na
lactate, 4; Na butyrate, 10; dextran, 0.6%; oxygenated with 95%
O2/5% CO2; final pH 7.4), and then subjected to a 15-minute
rewarming period. The preparations were reoxygenated and split
into four to eight equal aliquots, depending on the experiment.
The aliquots were placed into a 10 ml siliconized Erlenmeyer flask
(1.25 ml PTS suspension; ;2 to 4 mg PTS protein/ml). All
experiments were performed in a heated shaking water bath
maintained at 36 to 37°C. Lethal cell injury and lipid peroxidation
were assessed at the end of most experiments by % lactate
dehydrogenase (LDH) release and malondialdehyde (MDA) con-
centrations, respectively [18].
Glutathione/cysteine effects on proximal tubule segments under
normal conditions and during Fe21 attack
Six separate PTS preparations, each divided into six equal
aliquots, were simultaneously incubated under one of the follow-
ing conditions: (1) control conditions (no additions); (2) 4 mM
GSH (G 6529; Sigma Chemicals, St. Louis, MO, USA); (3) 4 mM
cysteine (14035; United States Biochem Corp; Cleveland, OH,
USA); (4) 3 mM FeCl2 addition [from a 10 mM stock solution
prepared in deoxygenated (95% N2/5% CO2 gassed) PTS buffer
just prior to its addition]; (5) FeCl2 1 4 mM GSH; and (6) FeCl2
1 3 mM cysteine. After completing the 30 minute incubations, the
extent of cell injury (% LDH release, MDA generation) was
assessed. [Note: the dose of Fe21 employed was first shown to
have no independent impact on LDH or the LDH assay.]
Glutathione and cysteine effects on ferric (Fe31) iron-induced
proximal tubule segment injury
The following experiment assessed the effects of GSH and
cysteine on the expression of Fe31-induced PTS injury. Six
separate PTS preparations were each divided into six equal
aliquots and then they were treated exactly as noted above, except
that 3 mM FeCl3 (prepared as noted above) was substituted for the
FeCl2 challenge. After the 30 minute incubations, % LDH release
and MDA concentrations were assessed. [Note: the dose of Fe31
employed was first shown to have no independent impact on LDH
or the LDH assay.]
Glutathione and cysteine effects on H2O2-mediated proximal
tubule segment injury
Six sets of PTS were each divided into four equal aliquots and
incubated as follows: (1) control incubation; (2) 4 mM H2O2
addition; (3) H2O2 1 4 mM GSH; and (4) H2O2 1 4 mM cysteine.
After 30 minute exposures, cell injury was assessed as noted
above.
H2O2 and iron as determinants of glutathione/cysteine
mediated proximal tubule segment injury
GSH and cysteine effects on PTS H2O2 levels. Since thiol
autoxidation can result in H2O2 generation [19, 20], the impacts of
GSH and cysteine on PTS H2O2 burdens were assessed. Six sets of
PTS were each divided into four aliquots, as follows: (1, 2)
incubation under control conditions for one minute (baseline) or
30 minutes; (3, 4) 30 minute incubations in the presence of either
4 mM GSH or cysteine. H2O2 production (rise in H2O2 levels from
1 to 30 min) was assessed by the phenol red/horseradish peroxi-
dase technique [21], as previously described for PTS [10]. In
addition, GSH and cysteine were individually added to PTS buffer
(that is, in the absence of PTS) to ascertain whether H2O2
generation resulted. These results were compared to those ob-
tained with buffer alone (that is, no GSH or cysteine addition).
Impact of catalase and deferoxamine on GSH- and cysteine-
induced PTS oxidation. To assess the impacts of H2O2 and free
iron on GSH/cysteine-mediated tubule oxidation, eight PTS prep-
arations were each divided into four equal aliquots and incubated
as follows: (1) control conditions; (2) with either 4 mM GSH or
cysteine; (3) with GSH or cysteine 1 5000 units/ml catalase (from
bovine liver; Sigma C-40); or (4) with GSH or cysteine 1 2 mM
DFO. At the completion of the incubations, lipid peroxidation
and LDH release were assessed.
Impact of catalase on Fe31 induced cytotoxicity. Both GSH and
cysteine were found to exacerbate Fe31-induced lipid peroxida-
tion and cell injury (see Results). The following experiment
sought to determine whether the sulfhydryl group autoxidation,
resulting in H2O2 generation [19, 20], was responsible. Four PTS
preparations were each divided into eight equal aliquots and
incubated 3 30 minutes as follows: (1) control incubation; (2)
control incubation 1 5000 units/ml of catalase; (3) 3 mM Fe31; (4)
Fe31 1 catalase; (5) Fe31 1 4 mM GSH; (6) Fe31 1 GSH 1
catalase; (7) Fe31 1 4 mM cysteine; (8) Fe31 1 cysteine 1
catalase. % LDH release and MDA generation were then as-
sessed.
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Fe21 and Fe31 interactions as a determinant of proximal
tubular injury
Since Fe redox cycling is a critical determinant of free radical-
induced tubular injury, the following experiment assessed whether
the relative balance between Fe21 and Fe31 (which can be
impacted by thiol catalyzed redox reactions) alters the expression
of iron cytotoxicity. To this end, four sets of PTS were each
divided into four aliquots and incubated as follows: (1) control
conditions; (2) 3 mM Fe21; (3) 3 mM Fe31; and (4) 3 mM Fe21 1
3 mM Fe31. LDH release and MDA levels were assessed 30
minutes later.
HK-2 model of myoglobin cytotoxicity
Whereas the above PTS experiments analyzed GSH and cys-
teine effects on individual components of heme protein-initiated
oxidant stress (Fe21, Fe31, H2O2), the following experiment was
undertaken to analyze the impact of GSH and cysteine on a fully
integrated model of heme protein attack. To this end, a previously
reported cell culture model of myoglobin cytotoxicity was em-
ployed [5]. In brief, HK-2 cells (an immortalized proximal tubular
cell line derived from normal human kidney) were grown in T75
Costar flasks in keratinocyte serum free medium (K-SFM; Gibco
BRL, Grand Island, NY, USA), as previously described [5].
Approximately 18 hours prior to experimentation, the flasks were
trypsinized, and the detached cells were re-plated in 6 or 24 well
Costar cluster plates. The cells were then subjected to: (a) normal
culture conditions, (b) a myoglobin challenge; (c) a myoglobin
challenge 1 test reactant(s); or (d) test reactants alone. The
myoglobin challenge was prepared as follows: horse skeletal
muscle myoglobin (Sigma, M0630) was suspended (40 mg/ml) in
Hanks’ buffered salt solution (with Ca21/Mg21) and sonicated.
Ascorbic acid (12 mM) was added to the myoglobin stock to effect
a metmyoglobin 3 myoglobin conversion (pH maintained at 7.4
with NaOH). [Note: commercially available myoglobin is in the
metmyoglobin form, which does not induce lethal HK-2 cell
injury]. After incubating the stock myoglobin solution for one
hour at 22°C, myoglobin was added to the cells to achieve a 10
mg/ml myoglobin concentration (3 mM ascorbate). (This amount
of ascorbate has no independent effect on HK-2 cell viability with
or without the employed test agents [5]; this was further con-
firmed throughout each of the present experiments). After com-
pleting 24 hour incubations with myoglobin 6 test reactants, or
test reactants alone, the extent of lethal cell injury was assessed by
calculating % LDH release [5]. [Note: the myoglobin challenge
did not independently affect the LDH assay]. All experiments
were performed in at least triplicate on any given day, and on 3 to
10 separate occasions.
Effects of glutathione and cysteine on the expression of myoglobin
toxicity in HK-2 cells. HK-2 cells were co-cultured as follows: (1)
control conditions; (2) myoglobin challenge; (3) myoglobin 1 4
mM GSH; (4) myoglobin 1 4 mM cysteine; (5) 4 mM GSH alone;
(6) 4 mM cysteine alone. After 24 hours, cell viability was assessed.
To further assess the impact of GSH on the expression of
myoglobin toxicity, HK-2 cells were pre-treated for 18 hours with
4 mM GSH (starting immediately after adding the cells to the
cluster plates). After completing this 18 hour pre-treatment
period, the media was replaced with fresh media containing 4 mM
GSH, and then the cells were subjected to the standard 24-hour
myoglobin challenge. Co-incubated cells treated in the same
fashion but without any GSH treatment/pre-treatment served as
controls. After 24-hour myoglobin exposures, % LDH release was
assessed.
Effect of GSH depletion on the expression of myoglobin cytotox-
icity in HK-2 cells. As an alternative approach to exploring the
impact of GSH on the expression of myoglobin toxicity, the effect
of GSH depletion (as opposed to GSH supplementation) was
assessed. To this end, HK-2 cells were exposed to the standard
myoglobin challenge in the presence or absence of 1 mM BSO
(1-buthionine-[S,R]-sulfoxamine; Sigma, B2515), a GSH synthase
inhibitor (such as [12, 14]). BSO was added in either one of two
ways: (a) 18 hours prior to and then during the myoglobin
challenge; and (b) only at the time of the myoglobin challenge. To
assess the independent effect of BSO on HK-2 viability, it was
added in the same fashion to co-cultured HK-2 cells in the
absence of the myoglobin challenge.
BSO, GSH, and cysteine effects on HK-2 cell non-protein sulfhy-
dryl (NP-SH) content. The following experments were undertaken
to confirm that BSO, GSH, and cysteine additions had their
expected effects on intracellular thiol content:
(a.) BSO. HK-2 cells were plated in six-well cluster plates and
incubated in the absence or presence of 1 mM BSO for 24 hours.
The wells were then washed with Hanks balanced salt solution,
the cells were extracted with 5% trichloroacetic acid, and then
they were assayed for NP-SH content using Ellman’s reagent (N 5
4 separate determinations of each) [10, 22]. Of note is that ;90%
and ;10% of the total NP-SH content is composed of GSH and
cysteine, respectively].
(b.) GSH and cysteine. HK-2 cells were cultured for 24 hours in
six well plates either in the presence of 4 mM GSH, 4 mM cysteine,
or under control conditions. The media were then removed, the
cells washed 3 2, extracted in trichloroacetic acid, and assayed for
NP-SH. Blank wells (no cells), spiked with either GSH or cysteine
and treated as above, were used to determine contaminating
NP-SH levels (that is, remaining after the GSH/cysteine additions
and subsequent washouts). These values were subtracted from
those obtained from the GSH or cysteine treated cells (N 5 4
separate determinations each).
Effect of glutathione and cysteine on iron mediated injury in
LLC-PK1 cells
The above experiments indicated that GSH exacerabates,
whereas cysteine protects against, myoglobin-induced oxidant
attack (see Results). To assess whether these results are uniquely
confined to this particular injury model, the effects of GSH and
cysteine on: (1) a different model of oxidant injury, (2) performed
in a different cell line, (3) under different culture conditions, and
(4) with a different injury endpoint were assessed. To this end,
LLC-PK1 cells (ATCC, Rockville, MD, USA) were cultured in
T75 Costar flasks with RPMI-HEPES 1 3% fetal calf serum (1
mM pyruvic acid, 2 mM glutamine, 25 units/ml penicillin 1 25
mg/ml streptomycin additions). Approximately 18 hours prior to
experimentation, the flasks were trypinsized and the cells seeded
into 24-well Costar cluster plates. The cells were then exposed to
one of the following treatments: (1) no additions; (2) 4 mM GSH;
(3) 4 mM cysteine; (4) 25 mM ferrous ammonium sulfate com-
plexed with 25 mM hydroxyquinoline (Fe/HQ), (HQ: a sid-
erophore, used to facilitate iron gaining intracellular access) [23];
(5) 25 mM Fe/HQ 1 4 mM GSH; and (6) Fe/HQ 1 4 mM cysteine.
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After a 24-hour incubation, cell injury was assessed by vital dye
uptake (ethidium bromide; acridine orange as a counter stain)
[24].
Exploring potential determinants of cysteine’s cytoprotective
effect
The above experiments demonstrated that cysteine can exert a
dramatic cytoprotective effect against myoglobin or Fe/HQ-in-
duced cellular attack. The following experiments explored some
potential determinants of this effect:
(1.) Is cysteine’s protective action mediated via its metabolism to
pyruvate? Pyruvic acid, a major end product of cysteine metabo-
lism, can scavenge H2O2 [20, 25]. Hence, pyruvate generation
could be a potential mechanism for cysteine’s protective action.
To test for this possibility, HK-2 cells were cultured with myoglo-
bin 6 5 mM Na pyruvate. Cells incubated 6 pyruvate in the
absence of myoglobin were used to establish independent pyru-
vate effects. After 24 hour exposures, the % LDH release was
assessed.
(2.) Is cysteine’s protective action mediated via sublethal oxidant
stress? Abundant information indicates that sublethal oxidant
stress can induce cytoprotection against superimposed oxidant
insults, either via a direct alteration in membrane integrity [26] or
via the upregulation of cytoprotective proteins (such as ferritin)
[6, 7]. To ascertain whether cysteine’s protective action is medi-
ated via this action, the following experiment assessed whether a
structurally related “pro-oxidant” (homocysteine) could repro-
duce cysteine’s cytoprotective effect. HK-2 cells were challenged
with myoglobin 6 4 mM homocysteine. Cells cultured 6 4 mM
homocysteine in the absence of myoglobin assessed homocys-
teine’s independent effect. LDH release was determined 24 hours
later.
(3.) Is cysteine’s protective action dependent on de novo protein
synthesis? The following experiment ascertained whether cysteine
incorporation into protein is required for the expression of its
cytoprotective effect. HK-2 cells were subjected to the following
treatments: (a) normal culture conditions 6 0.1 mM cyclohexi-
mide; (b) myoglobin 6 cycloheximide; and (c) myoglobin 1 4 mM
cysteine 6 cycloheximide. This dose of cycloheximide has previ-
ously been demonstrated to suppress HK-2 protein synthesis by
. 98% [27]. % LDH release was assessed 24 hours later.
(4.) Is cysteine’s cytoprotective effect relatively specific for oxidant
forms of attack? The following experiment was undertaken to
ascertain whether cysteine can protect against non-oxidant, as well
as oxidant, forms of attack. LLC-PK1 cells were exposed to a
previously utilized ATP depletion/Ca21 overload protocol (7.5 mM
antimycin A 1 20 mM 2-deoxyglucose 1 10 mM Ca21 ionophore
A23187) for two hours 6 4 mM cysteine. Two hours later, % LDH
release was assessed.
Calculations and statistics
All values are presented as means 6 1 SEM. Statistical compar-
isons were performed by paired or unpaired Student’s t-test, as
appropriate. If multiple comparisons were made, the Bonferroni
correction was applied.
RESULTS
Effects of glutathione and cysteine on isolated proximal tubule
viability
GSH and cysteine effects on normal tubules. Figure 1 presents
the composite results obtained when GSH and cysteine were
added to PTS maintained under otherwise normal incubation
conditions. GSH did not alter cell viability (LDH release), but it
did evoke significant lipid peroxidation, causing a doubling of
MDA levels by the end of the 30 minute incubations. Equimolar
cysteine exerted an even greater pro-oxidant effect, raising MDA
to four times normal levels. A correlate of the greater cysteine-
mediated lipid peroxidation was a significant increase in LDH
release (rising from 16 6 1% to 25 6 3%; P , 0.005).
GSH and cysteine effects on Fe21 mediated oxidant stress. Fe21
was markedly cytotoxic to PTS, raising LDH release from 17 6
2% to 48 6 3% (Fig. 2A). Although GSH and cysteine were each
pro-oxidant to normal PTS (see above), each induced an approx-
imate 50% reduction in Fe21-induced LDH release (Fig. 2A).
However, this cytoprotection was associated with only mild (and
in the case of GSH, nonsignificant) reductions in MDA content
(Fig. 2B).
GSH and cysteine effects on Fe31 mediated oxidant stress. FeCl3,
in contrast to FeCl2, slightly decreased (rather than increased)
LDH release (P , 0.005; Fig. 3A). In further contrast to the
findings with Fe21 (where GSH and cysteine decreased % LDH
release), with the Fe31 challenge, GSH and cysteine each in-
creased LDH release (P , 0.03; vs. Fe31 alone). Correlates of this
Fig. 1. Glutathione (GSH) and cysteine effects
on isolated proximal tubule segments (PTS) in
the absence of a superimposed oxidant
challenge. Addition of 4 mM GSH did not alter
LDH release during the course of 30 minutes
oxygenated incubations (A), but it doubled the
extent of lipid peroxidation, as assessed by
malondialdehyde, MDA, concentrations (B). In
contrast, cysteine (cys) quadrupled MDA levels,
and this correlated with a modest increase in
lethal cell injury, as assessed by LDH release.
Abbreviation C is control incubations (no
additions).
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injury exacerbation were dramatic and synergistic increases in
lipid peroxidation (that is, the MDA increments were greater than
could be ascribed to the sum of independent Fe31 1 GSH or
cysteine effects).
GSH and cysteine effects on H2O2 mediated oxidant stress. H2O2
induced overt cytotoxicity, as reflected by substantial increments
in both % LDH release and MDA generation above control
values (Fig. 4). GSH addition approximately halved the extent of
H2O2-induced LDH release (Fig. 4A), despite the fact that only a
nonsignificant reduction in MDA levels resulted (Fig. 4B). In
contrast, cysteine significantly increased both LDH release and
MDA generation.
H2O2 and free iron as determinants of glutathione/cysteine-
mediated proximal tubular segment injury
H2O2 generation. As shown in Figure 5A, the addition of either
GSH or cysteine to cell free (PTS) buffer markedly increased
H2O2 generation compared to buffer alone (which contained no
detectable H2O2). The increase was ;33 higher with cysteine
(P , 0.005). As depicted in Figure 5B, PTS generated substantial
amounts of H2O2 over the course of 30-minute control (c)
incubations (vs. baseline, BL, values). GSH decreased PTS H2O2
levels, which was consistent with H2O2 scavenging via glutathione
peroxidase. In contrast to its ability to generate H2O2 in a cell free
system, in the presence of PTS, cysteine tended to blunt, rather
than raise, PTS H2O2 expression.
Impact of catalase and DFO on GSH/cysteine-mediated lipid
peroxidation. As shown in Figure 6, catalase (Cat) failed to
decrease GSH- or cysteine-induced lipid peroxidation in normal
PTS. Conversely, DFO completely abrogated lipid peroxidation in
response to both the GSH and cysteine challenges.
Impact of catalase on the GSH/cysteine-mediated exacerbation of
Fe31 attack. Catalase did not blunt either LDH release or MDA
generation under control conditions, in the presence of Fe31, or
in the presence of the combined Fe31/GSH or Fe31/cysteine
challenges (data not depicted). This indicates that the GSH/
cysteine-induced exacerbations of LDH release and lipid peroxi-
dation in the presence of Fe31 (Fig. 3 experiments) were disso-
ciated from increased H2O2 generation.
Fig. 2. Glutathione (GSH) and cysteine effects
on proximal tubular segments (PTS) in the
presence of an Fe21 challenge. FeCl2 addition
to PTS caused ;50% cell death (LDH release)
and an approximate 20 times increase in MDA
content. GSH and cysteine (Cys) blunted ;40
to 50% of the iron induced LDH release. This
cytoprotection was associated with only small
decrements in MDA levels. Abbreviations are:
C, control incubation conditions; 0, Fe21
challenge in the absence of any other
treatment.
Fig. 3. Glutathione (GSH) and cysteine (cys) effects on proximal tubule
segments (PTS) in the presence of an Fe31 challenge. The addition of
FeCl3 to PTS (in the absence of GSH or cysteine) caused slight, but highly
significant, reductions in % LDH release (P , 0.005; consistent with
previous observations from this laboratory [31]). Conversely, when Fe31
was present with either GSH or cysteine, significant increases in % LDH
release resulted (vs. Fe31 alone; P , 0.03). Fe31 alone caused only a slight
increase in MDA levels. However, in the presence of GSH or cys, striking
and synergistic lipid peroxidation resulted (that is, the observed incre-
ments were greater than the sum of independent Fe31 1 GSH or cys
effects; the latter from Fig. 1). Abbreviations are: C, control incubation
conditions; 0, Fe31 challenge in the absence of any other treatment.
Fig. 4. Glutathione (GSH) and cysteine effects on proximal tubule
segments (PTS) in the presence of an H2O2 challenge. The addition of
H2O2 to PTS caused a significant LDH release and MDA generation.
GSH significantly attenuated the H2O2-induced LDH release, but not the
MDA increments. Conversely, cysteine (cys) significantly increased both
injury parameters. Abbreviations are: C, control incubation conditions; 0,
H2O2 challenge in the absence of any other treatment.
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Fe21/Fe31 interactions as a determinant of proximal tubular
injury
As previously observed, Fe21 induced proximal tubular cyto-
toxicity (LDH release), whereas Fe31 slightly decreased LDH
release from normal PTS (Fig. 7). When added to the Fe21
challenge, Fe31 conferred a modest, but highly significant, cyto-
protective effect. This was observed in the absence of a decrease
in Fe21 mediated MDA generation.
Effect of glutathione and cysteine on the expression of
myoglobin toxicity in HK-2 cells
GSH and cysteine effects on myoglobin-induced cytotoxicity. As
shown in Figure 8 (left panel), neither GSH nor cysteine exerted
an independent cytotoxic effect on HK-2 cells. Myoglobin caused
significant cytotoxicity, raising LDH release to 52 6 2%. GSH
addition during the myoglobin challenge increased the extent of
this cell injury, raising LDH release from ;52% to ;70% (P ,
0.0001; Fig. 8, right panel). In striking contrast, cysteine exerted a
marked cytoprotective effect, more than halving the extent of
myoglobin-induced cell death (Fig. 8, right panel).
Treating HK-2 cells with GSH for 18 hours prior to and during
the myoglobin challenge also exacerbated the extent of myoglo-
bin-induced cell death (raising LDH release from 57 6 4% to
75 6 4%; P , 0.01). Thus, the failure of GSH to exert the
expected protective effect could not simply be explained by an
insufficient length of time for GSH cellular uptake prior to the
myoglobin challenge. [Notes: additional experiments, not pre-
sented, demonstrated that neither 4 mM glycine nor glutamate
altered the severity of myoglobin cytotoxicity (indicating that
GSH catabolism to these amino acids did not account for GSH’s
adverse effects). That glycine failed to protect against myoglobin
cytotoxicity is consistent with previous observations that iron-
mediated tubular injury is a relatively glycine resistant event [23].
Fig. 5. Glutathione (GSH) and cysteine effects
on H2O2 generation. (A) 4 mM GSH or cysteine
was added to PTS buffer (no cells present) and
H2O2 generation was assessed over the ensuing
30 minutes. In the absence of GSH or cysteine
(controls, C), barely detectable or no H2O2 was
detected. However, both GSH and cysteine
(cys) caused marked H2O2 generation
(particularly with cys; P , 0.005 vs. GSH). (B)
Normal PTS generated substantial amounts of
H2O2 over the course of a 30 minutes control
(C) incubation, with values rising from barely
detectable levels at baseline (BL) to ;8.5 nmol/
mg protein at 30 minutes. Although GSH
significantly increased H2O2 production in PTS
buffer (A), in the presence of PTS, GSH
significantly lowered H2O2 levels (consistent
with either H2O2 scavenging via GSH-mediated
glutathione peroxidase activity, or decreased
H2O2 production by PTS; see text). That thiols
may decrease PTS H2O2 production is further
suggested by the fact that cys slightly lowered,
rather than induced the expected increase in
H2O2 levels.
Fig. 6. DFO and catalase effects on thiol-
mediated peroxidative proximal tubular
segment (PTS) injury. Glutathione (GSH)
induced lipid peroxidation in normal PTS (A), a
reaction which was blocked by iron chelation
(DFO) but not by H2O2 scavenging therapy
(catalase, Cat). The same results were observed
with cysteine (cys) as the pro-oxidant challenge
(B). Hence, these two thiols apparently induced
their pro-oxidant effects via an iron dependent/
H2O2 independent mechanism.
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Effect of BSO on the expression of myoglobin toxicity
Treatment of HK-2 cells with BSO induced modest, but signif-
icant cytotoxicity (up to 28% LDH release; Fig. 9). Nevertheless,
BSO conferred modest, but highly signficant, protection against
the myoglobin challenge, irrespective of whether the BSO pre-
treatment protocol or the concomitant treatment protocol was
employed. [Note: if one “corrects” for BSO’s independent toxic
effect (that is, subtracting BSO-mediated LDH release from the
extent of Mgb/BSO-associated LDH release), it appears that BSO
caused an approximate 40% reduction in myoglobin cytotoxicity.
These “corrected” (c) results are depicted as “BSOc” in Figure 9].
Effect of BSO, glutathione, and cysteine on HK-2 cell NP-SH
content
As shown in Figure 10, BSO significantly decreased NP-SH
content (confirming that it induced a GSH depletion state). GSH
and cysteine significantly and equally increased NP-SH content
(confirming that their addition to the media was associated with
increased cell uptake).
LLC-PK1 experiments
Neither GSH nor cysteine altered vital dye uptake by LLC-PK1
cells (Fig. 11, left panel). Fe/HQ addition, in the absence of other
reactants, induced 71 6 3% cell death (vital dye uptake). GSH
caused a modest, but highly significant, increase in the extent of
Fe/HQ induced cell death (to 88 6 3%, Fig. 11, middle panel).
Conversely, cysteine eliminated 2/3rds of Fe/HQ’s cytotoxic effect
(Fig. 11, right panel). Hence, these GSH and cysteine results fully
recapitulated the findings with GSH and cysteine in the HK-2
model of myoglobin-induced cell death.
Potential determinants of cysteine’s cytoprotective effects
Impact of pyruvate on myoglobin-induced HK-2 toxicity. Addition
of pyruvate (Pyr) did not attenuate myoglobin cytotoxicity (Fig.
12A). It also did not alter % LDH release in the absence of the
myoglobin challenge, which indicates that its failure to protect
against myoglobin was not due to an independent cytotoxic effect.
Influence of homocysteine on myoglobin-induced HK-2 toxicity.
As shown in Figure 12B, homocysteine (HC) worsened myoglobin
toxicity without exerting an independent cytotoxic effect (that is,
Fig. 7. Impact of Fe31 on the expression of
Fe21 toxicity. Addition of 3 mM Fe31 slightly,
but significantly, lowered LDH release from
tubules over the course of a control 30-minute
incubation. When 3 mM Fe31 was added to a 3
mM Fe21 challenge, a modest reduction in
LDH release resulted. Thus, these observations
extend previous observations that Fe31 can
exert cytoprotective effects against PTS damage
[31]. This cytoprotection was observed without
a correlative reduction in MDA generation.
Fig. 8. Glutathione (GSH) and cysteine effects
on myoglobin (Mgb) toxicity in HK-2 cells. (A)
Under control incubation conditions, neither
GSH nor cysteine (cys) induced any
cytotoxicity, as assessed by LDH release. (B)
However, in the presence of myoglobin, GSH
induced a modest, but highly significant
worsening of LDH release. In contrast, cys
conferred a marked cytoprotective effect
(approximately halving the extent of myoglobin-
induced cell death).
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in the absence of myoglobin). Thus, it similated GSH’s injurious,
rather than cysteine’s protective, action against myoglobin cyto-
toxicity.
Impact of protein synthesis inhibition on cysteine-induced cytopro-
tection. As shown in Figure 13, cysteine-mediated cytoprotection
was still expressed in the presence of cycloheximide. This was
despite the fact that cycloheximide exerted a slight independent
cytotoxic effect (that is, in the absence of the myoglobin chal-
lenge).
Impact of cysteine on a non-oxidant form of cell attack. Cysteine’s
ability to abrogate oxidant injury appeared to be challenge
specific, since it as well as GSH slightly, but significantly, worsened
the extent of ATP depletion/Ca21 ionophore-induced cell death
(challenge alone, 75 6 4% cell death; challenge 1 GSH, 82 6 2%
cell death; challenge 1 cysteine, 82 6 2% cell death; P , 0.05 for
GSH or cysteine vs. challenge alone).
DISCUSSION
A key piece of information used to support the concept of an
oxidant mode of tissue injury is that an antioxidant agent elicits a
cytoprotective effect. However, a number of potential caveats to
this experimental approach exist. First, many antioxidants have
nonspecific actions, obfuscating data interpretation; second, de-
pending on cellular redox status, antioxidants can exert either pro-
or antioxidant influences [19]; and third, antioxidants can be
rapidly metabolized into bioactive constituents that secondarily
impact tissue damage. GSH is a typical case in point. Since it is
subjected to intracellular redox reactions, it can contribute to free
radical generation [19, 28]. It is also a source of cysteine and
glycine, which can secondarily alter tissue damage. Weinberg’s
classic demonstration that glycine is responsible for GSH’s “cyto-
protective action” against hypoxic tubular damage underscores
the finding that protection with an antioxidant and an antioxidant
mode of tissue injury are not necessarily synonymous [29].
Given that GSH can exert protective [14] and injurious [4, 5]
effects on heme protein-induced tubular damage, the present
study was undertaken to help dissect some potential underlying
reasons for these results. As a starting point, the impact of GSH
and cysteine on normal PTS was assessed. As shown in Figure 1,
both GSH and cysteine exerted marked pro-oxidants effects: GSH
and cysteine doubled and quadrupled the extent of lipid peroxi-
dation, respectively, and in the case of cysteine, modest cytotox-
icity (increased LDH release) resulted. At least two theoretical
mechanisms may underlie these findings: (1) spontaneous thiol
autoxidation, resulting in H2O2 generation [19, 20, 25]; and (2) a
reduction of endogenous free iron from the Fe31 to the Fe21
form [19]. Since Fe21 is cytotoxic [3, 30, 31] (Fig. 2 data), whereas
Fe31 can be cytoprotective ([31] and discussed below), an
Fig. 9. BSO mediated glutathione (GSH)
depletion in HK-2 cells: Effect on myoglobin
toxicity. (A; pretreatment) BSO was added to
HK-2 cells for 18 hours (pre-treatment), and
then the cells were exposed to BSO for an
additional 24 hours either in the absence (M)
or the presence (u) of the myoglobin (Mgb)
challenge. BSO exposure induced significant
cytotoxicity in the absence of the myoglobin
challenge (increase in LDH release from 8 to
28%; P , 0.01). Despite this independent
toxicity, BSO conferred modest, but significant
protection against the myoglobin challenge
(P , 0.01). “Correcting” for the independent
BSO effect [BSO(c); that is, subtracting out the
independent BSO effect from the LDH release
induced by myoglobin/BSO treatment] suggests
that BSO depletion mitigated ; 40% of
myoglobin’s direct cytotoxic effect. (B;
concomitant treatment) These experiments
were conducted in the same fashion as those in
(A), except that the BSO exposure was only for
24 hours (in the presence or absence of the
Mgb challenge). These results were comparable
to those observed with the BSO pre-treatment
protocol.
Fig. 10. Impact of glutathione (GSH), cysteine, and BSO treatment on
HK-2 cell NP-SH content. Cells were co-cultured under control conditions
or in the presence of 4 mM GSH, 4 mM cysteine (cys), or 1 mM BSO for
24 hours and then non-protein sulfhydryl levels (NP-SH) were assessed.
Treatment group values were expressed as a % of those observed in
control cells. GSH and cys induced ;70% increments, whereas BSO
caused ;80% decrements in NP-SH content.
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Fe313Fe21 conversion would be expected to exert an injury-
potentiating effect. The available data strongly suggest that an
iron, rather than an H2O2, dependent mechanism was responsible
for the thiol-induced injury in normal PTS. First, DFO completely
blocked GSH’s and cysteine’s pro-oxidant effects (Fig. 6), con-
firming that an iron dependent mechanism was involved. Second,
catalase did not diminish either the GSH- or cysteine-mediated
oxidative injury (Fig. 6). Third, GSH and cysteine tended to
decrease, rather than increase, PTS H2O2 levels despite their
ability to produce H2O2 in a cell free system (Fig. 5). The reason
for the latter result remains unknown. However, given that the
mitochondrion is the dominant site of PTS H2O2 generation [10],
the data strongly suggest that free thiol loading may decrease
reactive oxidant production at this site.
Since GSH and cysteine caused an iron dependent form of
injury in normal PTS, one would predict that each would poten-
tiate injury imposed by exogenous iron attack. To explore this
thesis, the effects of GSH and cysteine on inorganic iron (Fe21 or
Fe31) mediated PTS damage were assessed. The results obtained
graphically demonstrate the complexity of this issue, since diver-
gent results were obtained depending on the redox status of the
employed iron challenge. As illustrated in Figure 2, both GSH and
cysteine substantially mitigated Fe21 mediated LDH release (a
result that could simply result from complexing free iron, limiting
its toxicity [19, 20]). Of interest, only trivial MDA reductions were
correlates of this cytoprotection, consistent with our previous
observations that cell lysis and lipid peroxidation are not tightly,
or even directly, linked [3, 30, 31]. In contrast, both GSH and
cysteine slightly, but significantly worsened LDH release and
induced synergistic lipid peroxidation in the presence of the Fe31
challenge, reminiscent of their ability to provoke cell injury in
normal PTS. Once again, a thiol mediated reduction of cytopro-
tective Fe31, with the generation of cytotoxic Fe21, could explain
these results. Thus, the above PTS experiments provide the
following three insights: (1) GSH and cysteine are each pro-
oxidant when added to normal tubules; (2) they are each antiox-
idant in the presence of cytotoxic ferrous iron; and (3) they can
each unmask ferric iron’s pro-oxidant effects.
As is clear from the above findings, iron’s redox status is a
critical determinant of whether thiol supplementation exerts a
pro- or antioxidant effect. Further complicating this issue is that
Fe31 can attenuate apparently diverse forms of tubular damage.
As previously reported, Fe31 addition to PTS can significantly
improve cell viability under both normal incubation conditions
Fig. 11. Effects of glutathione (GSH) and
cysteine on the expression of iron mediated
oxidant injury in LLC-PK1 cells. Neither GSH
nor cysteine (cys) altered LLC-PK1 viability
(assessed by vital dye exclusion) under normal
culture conditions. Addition of an iron-
mediated oxidant challenge (Fe/HQ: 25 mM Fe
complexed to hydroxyquinoline) caused an
approximate 70% loss of cell viability. GSH
significantly worsened this toxicity (to 88% cell
death; P , 0.0003), whereas cys conferred a
dramatic cytoprotective effect (eliminating ;2/
3rds of Fe/HQ toxicity; P , 1 3 10210).
Fig. 12. Pyruvate (Pyr) and homocysteine (HC)
effects on myoglobin-induced HK-2 cytotoxicity.
(A) Pyruvate failed to alter myoglobin’s (Mgb)
cytotoxic effect, and it had no independent
influence on HK-2 viability (in absence of
Mgb). (B) Addition of 4 mM homocysteine
(HC) slightly, but significantly worsened
myoglobin’s cytotoxic effect (that is, it
mimicked GSH’s injury-potentiating, rather
than cysteine’s cytoprotective effect). In the
absence of myoglobin, HC had no independent
cytotoxic effect.
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and during ATP depletion-induced attack (hypoxia; antimycin A)
[31]. As shown here for the first time, Fe31 can also diminish
ferrous iron’s potent cytotoxic effect. The mechanism underlying
this cytoprotection remains incompletely defined [31]. However,
since shuttling of Fe21 to Fe31 (with electron donation, forming
free radicals) is critical to iron-mediated oxidant stress, it could
simply be that provision of Fe31 retards this Fe213Fe31 conver-
sion via “end product” inhibition, and hence, cytoprotection
results. Whatever the exact mechanism, one point seems clear:
since thiols exert pro- and antioxidant effects that can secondarily
impact iron’s redox status, they may exacerbate or protect against
iron-mediated attack.
Since H2O2, like iron, is a critical determinant of heme protein
toxicity [5, 9], the next set of experiments addressed the impact of
GSH and cysteine on H2O2 toxicity to PTS. In contrast to the
inorganic iron experiments in which GSH and cysteine acted
similarly, in the case of H2O2, GSH and cysteine exerted opposite
biological effects. With GSH, a significant reduction in H2O2
mediated-cell lysis was observed (from 41% to 26% LDH re-
lease), consistent with its ability to eliminate H2O2 via glutathione
peroxidase activity. In contrast, cysteine evoked a marked pro-
oxidant effect, reminiscent of its actions on control and Fe31
exposed PTS. These observations point out the potential complex-
ity of interpreting GSH effects on the expression of H2O2-
mediated tissue damage. On the one hand, GSH can clearly be
cytoprotective (such as by supporting GSH peroxidase activity);
however, since GSH can be rapidly degraded by normal and
injured proximal tubules, producing mM quantities of pro-oxidant
cysteine [11, 12, 29, 32, 33], increased H2O2 dependent injury
might also result.
Given that GSH exerts differing influences on differing com-
ponents of an oxidant tissue challenge, it is becomes impossible to
predict its overall impact on a fully integrated model of heme
protein toxicity (that is, in which Fe21/Fe31 and H2O2 are each
involved). This issue is further compounded by in vivo experi-
ments in which damage to multiple and interactive cell types (such
as glomerular, tubular, and endothelial) are involved. However,
since the proximal tubule is the dominant site of heme protein-
induced injury, GSH’s influence on the HK-2 cell culture model of
myoglobin toxicity was assessed. The results of those experiments
clearly demonstrate that GSH’s pro-oxidant actions can, in fact,
outweigh its antioxidant effects. Three pieces of evidence support
this view. First, GSH supplementation, administered either before
and/or at the time of a myoglobin challenge, exacerbated the
extent of cell death. That GSH did not alter HK-2 viability in the
absence of the myoglobin challenge indicates that this was not
simply due to additive (GSH 1 myoglobin) toxic effects. Second,
GSH depletion (imposed by BSO treatment/pre-treatment), con-
ferred a cytoprotective influence, supporting the concept that
GSH can, indeed, be toxic in the setting of heme protein attack.
Third, when a completely different form of oxidant injury (Fe/
HQ) was imposed on a different cell line (LLC-PK1), grown under
different culture conditions, and cell viability was assessed by a
different marker of cell injury (vital dye uptake), GSH, once
again, potentiated iron-mediated tubular cell death. Given the
complexity of the issues involved, a simple explanation for this
result is not at hand. However, at least three, and possibly
interactive, mechanisms may exist: (1) GSH autoxidation, (with
superoxide and H2O2 production) may have potentiated myoglo-
bin-driven oxidant stress; (2) provision of exogenous GSH under
oxidant conditions should increase GSH disulfide (G-SS-G) lev-
els. Since G-SS-G can be cytotoxic [by effecting disulfide exchange
(R-SS-G) with thiol containing proteins, altering their conforma-
tion/activity [19]], increased tissue injury may result; and (3) as
discussed previously, were GSH to faciliate an Fe31/Fe21 conver-
sion, this change could potentiate tissue damage.
Since GSH’s pro-oxidant actions stem from its thiol (cysteine)
content, it was assumed that cysteine would reproduce GSH’s
potentiation of myoglobin’s cytotoxic effect. This is particularly
true since cysteine, as opposed to GSH, worsened, rather than
protected against, H2O2 toxicity in PTS. However, cysteine in-
duced a marked cytoprotective influence, reducing myoglobin
toxicity in HK-2 cells by ;50%. Cysteine conferred even greater
cytoprotection against Fe/HQ toxicity in LLC-PK1 cells, under-
scoring that this was not simply a narrowly expressed effect,
confined to only one injury model in a single cell culture system.
This result has significant therapeutic implications. It certainly
raises the intriguing possibility that while GSH may mitigate in
vivo models of heme protein nephrotoxicity [14], it is possible that
this beneficial action could potentially stem from cysteine gener-
ation, rather than from a direct GSH effect. In a sense, then, this
may be analogous to GSH/glycine mediated cytoprotection [29],
that is, a GSH constituent (glycine), rather than GSH per se, might
mediate the observed beneficial effects.
The mechanism by which cysteine protects against myoglobin
and Fe/HQ toxicity remains unknown. However, a number of
possibilities have been excluded. First, it is not simply due to
nonspecific stabilization of the plasma membrane (preventing
LDH efflux or vital dye influx), since cysteine slightly worsened,
rather than protected against, ATP depletion/Ca21 ionophore-
induced cell death. This result also suggests that cysteine’s pro-
tective action is relatively specific for oxidant modes of attack.
Second, although cysteine’s major metabolic end product is
pyruvate, an H2O2 scavenger [20, 25, 34], pyruvate generation
cannot be implicated as the mechanism for cysteine’s protective
action. This is because pyruvate addition to HK-2 cells failed to
mitigate myoglobin-induced cell death. Third, cysteine flux into
some “cytoprotective protein” is a highly unlikely mechanism for
Fig. 13. Cysteine-induced cytoprotection is expressed in the setting of
protein synthesis inhibition. Cysteine (cys) was able to confer protection
against myoglobin toxicity in the presence of cycloheximide (CH) (A; P ,
0.001). This was despite the fact that cycloheximide exerted a modest
direct cytotoxic effect (B).
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its protective influence, since cycloheximide (which causes .98%
protein synthesis inhibition in HK-2 cells [27]) did not negate
cysteine’s cytoprotective effect. Fourth, although sublethal oxi-
dant insults (for example, [6, 7, 26, 31]) can protect against
superimposed forms of renal damage, this cannot readily explain
cysteine’s protective action. This is because homocysteine, which
is equally pro-oxidant to cysteine (data not shown), simulated
GSH’s cytotoxic rather than cysteine’s protective action against
myoglobin-induced attack. Of note, although homocysteine and
cysteine are structurally similar, they flux through different met-
abolic pathways. This suggests that cysteine-mediated cytoprotec-
tion could be mediated via some undefined intermediate metab-
olite(s), or perhaps via a cysteine-induced cell signaling event.
That cysteine can impact c-fos, c-jun, and JNK expression/activity
[35], and that cysteine and GSH may exert differential effects on
other signaling pathways, such as NFkB and ceramide [36–38;
unpublished data from this laboratory], provide a theoretical basis
for this latter possibility.
In conclusion, the present studies illustrate that GSH and
cysteine exert protean, and at times counterbalancing, influences
on tubular cell integrity: (1) each exerts an iron dependent
pro-oxidant effect on normal proximal tubules; (2) in the presence
of cytotoxic Fe21, each confers a cytoprotective effect; (3) con-
versely, in the presence of Fe31, GSH and cysteine initiate
synergistic lipid peroxidation and induce tubular cell death (pos-
sibly by reducing cytoprotectant Fe31 to cytotoxic Fe21); (4) GSH
mitigates, whereas cysteine exacerbates H2O2 cytotoxicity; and (5)
in the face of a fully integrated model of oxidant (myoglobin)
attack, GSH’s pro-oxidant influences may dominate over its antiox-
idant effects, culminating in a potentiation of cell death. Conversely,
cysteine can function as a surprisingly potent, and apparently com-
pound specific, cytoprotectant. Since GSH is rapidly catabolized to
cysteine within the kidney, the latter finding raises the intriguing
possibility that at least some of GSH’s protective actions against
heme protein-induced ARF could reflect cysteine release, rather
than a direct GSH-mediated antioxidant effect.
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